Patients at risk for contrast-induced nephropathy and mid-term effects after contrast administration: A prospective cohort study

Netherlands Journal of Medicine

Volumn 72, Issue 7, 2014, Pages 363-371

  Moos, S I ^a   Nagan, G ^a   de Weijert, R D ^a   van Vemde, D N H ^a   Stoker, J ^a   Bipat, S ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Acute kidney injury; Computed tomography; Contrast medium; Prevention; Risk factors

Indexed keywords

CONTRAST MEDIUM; CREATININE;

ACUTE KIDNEY INJURY; AGED; BLOOD; CHEMICALLY INDUCED; FEMALE; FLUID THERAPY; GLOMERULUS FILTRATION RATE; HUMAN; INCIDENCE; MALE; MIDDLE AGED; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

ACUTE KIDNEY INJURY; AGED; CONTRAST MEDIA; CREATININE; FEMALE; FLUID THERAPY; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL REPLACEMENT THERAPY; RISK FACTORS;

EID: 84906907307     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Weisbord SD, Chen H, Stone R, et al. Associations of increases in serum creatinine with mortality and length of hospital stay after coronary angiography. J Am Soc Nephrol. 2006;17:2871-7.
2. Morcos SK. Contrast media-induced nephrotoxicity - questions and answers. Br J Radiol. 1998;71:357-65.
3. Sandilands EA, Cameron S, Paterson F, et al. Mechanisms for an effect of acetylcysteine on renal function after exposure to radio-graphic contrast material: study protocol. BMC Clin Pharmacol. 2012;12:3. doi: 10.1186/1472-6904-12-3.
4. Mitchell AM, Jones AE, Tumlin JA, Kline JA. Incidence of contrast-induced nephropathy after contrast-enhanced computed tomography in the outpatient setting. Clin J Am Soc Nephrol. 2010;5:4-9.
5. van Rossum LK, Schreurs WMJ, Wetzels JFM, et al. Voorkomen van nierinsufficiëntie bij intravasculair gebruik van jodiumhoudende contrast-middelen. VMS. 2009. http://www.vmszorg.nl/page/vms_inline?nodeid=4667&subjectid=6704&configid=6492
6. van Dijk R, van Croonenborg JJ, van Logtesteijn SI, et al. Voorzorgsmaatregelen bij jodiumhoudende contrastmiddelen. CBO richtlijnen 2007. http://www.nvpc.nl/uploads/stand/2617_12_07_Voorzorgsmaatregelen.pdf
7. RIVM. 2012 Het aantal CT-onderzoeken voor de jaren 1991 tot en met 2011. Webpage http://www.rivm.nl/Onderwerpen/M/Medische_Stralingstoepassingen/Trends_en_stand_van_zaken/Diagnostiek#trend_aantallen.
8. Moos SI, van Vemde DNH, Stoker J, Bipat S. Contrast induced nephropathy in patients undergoing intravenous (IV) contrast enhanced computed tomography (CECT) and the relationship with risk factors: A meta-analysis. Eur J Radiol. 2013;82:e378-99.
9. Kooiman J, Pasha SM, Zondag W, et al. Meta-analysis: serum creatinine changes following contrast enhanced CT imaging. Eur J Radiol. 2012;81:2554-61.
10. Katzberg RW, Newhouse JH. Intravenous contrast medium-induced nephrotoxicity: is the medical risk really as great as we have come to believe? Radiology. 2010;256:21-8.
11. Moos SI, Stoker J, Nagan G, et al. Prediction of presence of kidney disease in a general patient population undergoing intravenous iodinated contrast enhanced computed tomography. Eur Radiol. 2014.
12. Moos SI, de Weijert RS, Stoker J, Bipat S. Cost of screening strategies for kidney disease before intravenous contrast administration. Neth J Med. 2014;5:271-80.
13. Gansevoort T, Gaillard M, Hemmelder H, Sijpkens J. Te grondig zoeken naar contrastnefropathie. Med Contact. 2010;65:2089-92.
14. Vermeeren MAP. Veiligheidsregels jagen kosten op. Med Contact. 2011;66:2073-6.
15. Balemans CEA, ten Dam MAGJ, Reichert LJ, Wetzels JFM. Impact nierschade niet bagatelliseren. Med Contact. 2010;65:2378-81.
16. Kooiman J, van der Molen AJ, Cannegieter SC. [Prevention of contrast- induced nephropathy: time for nuance and a new guideline]. Ned Tijdschr Geneeskd. 2013;157:A5475.
17. Rennenberg RJMW. Increasing the safety of healthcare: valuable, but at what cost? Ned Tijdschr Geneeskd. 2013;157:A6044.
18. de Boer JE, Boomkamp MD, Broekhuijsen F, et al. MKS Farmacotherapeutisch Kompas. 2014. In: Coll. voor Zorgverzekeringen. http://www.fk.cvz.nl/.
19. Lui EH, Lau KK, Polkinghorne K, et al. Efficacy of patient questionnaire in predicting renal dysfunction in outpatients older than 60 years of age prior to contrast-enhanced computed tomography. J Med Imaging Radiat Oncol. 2012;56:168-72.
20. Cohan RH, Dillman JR, Hartman RP, et al. ACR Manual on Contrast Media. Version 9. ACR, 2013, http://www.acr.org/quality-safety/resources//media/37D84428BF1D4E1B9A3A2918DA9E27A3.pdf/http://www.acr.org//media/ACR/Documents/PDF/QualitySafety/Resources/Contrast%20 Manual/2013_Contrast_Media.pdf.
21. Stacul F, van der Molen AJ, Reimer P, et al. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol. 2011;21:2527-41.
22. Davenport MS, Khalatbari S, Cohan RH, et al. Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material: risk stratification by using estimated glomerular filtration rate. Radiology. 2013;268:719-28.
23. Reddan D, Fishman EK. Radiologists' knowledge and perceptions of the impact of contrast-induced nephropathy and its risk factors when performing computed tomography examinations: a survey of European radiologists. Eur J Radiol. 2008;66:235-45.
24. Schilp J, Blok C, Langelaan M, et al. Guideline adherence for identification and hydration of high-risk hospital patients for contrast-induced nephropathy. BMC Nephrol. 2014;15:2.
25. Lencioni R, Fattori R, Morana G, Stacul F. Contrast-induced nephropathy in patients undergoing computed tomography (CONNECT) - a clinical problem in daily practice? A multicenter observational study. Acta Radiol. 2010;51:741-50.
26. Mcdonald JS, Mcdonald RJ, Comin J, et al. Frequency of acute Kidney Injury Following intravenous contrast Medium administration: A Systematic Review and Meta-Analysis. Radiology. 2013;267:119-28.
27. Aulicky P, Mikulík R, Goldemund D, et al. Safety of performing CT angiography in stroke patients treated with intravenous thrombolysis. J Neurol Neurosurg Psychiatry. 2010;81:783-7.
28. Ng CS, Shaw AD, Bell CS, Samuels JA. Effect of IV contrast medium on renal function in oncologic patients undergoing CT in ICU. Am J Roentgenol. 2010;195:414-22.
29. Tremblay LN, Tien H, Hamilton P, et al. Risk and Benefit of Intravenous Contrast in Trauma Patients with an Elevated Serum Creatinine. J Trauma Inj Infect Crit Care. 2005;59:1162-7.
30. Heller M, Husk G, Bowers W, et al. Contrast CT scans in the emergency department: Is there really an increased risk of adverse clinical outcomes? Acad Emerg Med. 2011;S231-232.
31. Polena S, Yang S, Alam R, et al. Nephropathy in critically ill patients without preexisting renal disease. Proc West Pharmacol Soc. 2005;48:134-5.
32. Carstensen M, Keer D, Rempel J, et al. Prevalence of risk factors for contrast-induced nephrotoxicity in outpatients undergoing intravenous contrast-enhanced computed tomography studies. Can Assoc Radiol J. 2012;63:177-82.